Whole Genome Sequencing for the Diagnosis of Rare Disorders
Campos Coelho, A. V.; Sales de Albuquerque, R.; dos Santos Gomes, C.; Bandeira do Nascimento Junior, J.; Santos de Oliveira, G.; Silva Moura, L. M.; Souto Mofatto, L.; Muniz Guedes, R. L.; Araujo Sequeira Barreiro, R.; Pinheiro Caraciolo, M.; de Andrade Oliveira, A. P.; Barbosa Teixeira, A. C.; Mascaro Cordeiro de Azevedo, B.; Dias Carlos, C.; Santos de Santana, L.; Cadena da Matta, M.; Martinelli Lima, M.; Bengala Zurro, N.; Yoshiko Yamada, R.; Pedigone Cintra, V.; Pereira Campilongo, G.; Borges Cherulli Colichio, G.; Martins Ribeiro da Silva, R.; Robledo DAngioli Costa Quaio, C.; Araujo More
Show abstract
BackgroundWhole-Genome Sequencing (WGS) and Whole-Transcriptome Sequencing (WTS) have emerged as transformative tools in the diagnosis of rare diseases with complex phenotypes. These technologies enable deep analysis of the genome and RNA expression, uncovering structural, intronic, non-coding, and mitochondrial variants that traditional methods might miss, thus facilitating the understanding of gene function and regulation. MethodsWe enrolled 8966 patients with suspected rare diseases or hereditary cancer risk syndromes from 21 centers throughout Brazil. Their genomes were sequenced with short, paired-end reads, and diagnostic reports were provided for 7614 of these patients. ResultsThe overall diagnostic yield was 35.8%, with an additional 5.6% of all Positive reports including gains from WGS compared to other diagnostic tests. In patients with pathogenic/likely pathogenic copy number or structural variants, WGS provided a 10.2% increase in diagnostic yield. Almost 1900 variant/phenotype interpretations were submitted to ClinVar. ConclusionWGS and WTS are proving to be invaluable resources for shortening the diagnostic odyssey of patients with rare diseases, providing crucial genomic diagnostics, and enriching genetic databases with variant interpretations from underrepresented populations. These technologies have the potential to significantly enhance the precision of healthcare in genetically diverse populations. Key Points for NEJM Editors and ReviewersO_LIScope: Largest Brazilian rare disease-focused sequencing project to date. C_LIO_LIFindings: A 35.8% diagnostic yield with notable additional detection of structural, deep intronic, non-coding, and mitochondrial variants. C_LIO_LIImpact: Shortens diagnostic odyssey for patients, enriches ClinVar with almost 1900 variant interpretations from underrepresented populations, and demonstrates potential cost-effectiveness of integrating WGS into public healthcare. These interim results underscore how national WGS programs can facilitate precision medicine, especially in genetically diverse and previously underrepresented populations. C_LI
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome Alert!: a standardized procedure for genomic variant reinterpretation and automated genotype-phenotype reassessment in clinical routine 95%
- Assessment of the variant prioritisation strategy for genomic newborn screening in the Generation Study 95%
- Genome sequencing reveals the impact of non-canonical exon inclusions in rare genetic disease 94%
Similar papers in this journal
- Re-evaluation and Re-analysis of 152 research exomes five years after the initial report reveals clinically relevant changes in 20% 96%
- BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations 96%
- Polycomb-associated and Trithorax-associated developmental conditions – phenotypic convergence and heterogeneity 94%
Similar papers in this journal
- Exome sequencing as a first-tier test for copy number variant detection : retrospective evaluation and prospective screening in 2418 cases 95%
- Assessing performance of pathogenicity predictors using clinically-relevant variant datasets 95%
- A comparative medical genomics approach may facilitate the interpretation of rare missense variation 94%
Similar papers in this journal
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 96%
- Genome Sequencing and Comprehensive Rare Variant Analysis of 465 Families with Neurodevelopmental Disorders 95%
- Identification of actionable genetic variants in 4,198 Scottish volunteers from the Viking Genes research cohort and implementation of return of results 94%
Similar papers in this journal
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 96%
- Biallelic truncation variants in ATP9A are associated with a novel autosomal recessive neurodevelopmental disorder 96%
- Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.